Mortality Impact of Stroke and Major Bleeding across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure with Prevalent Atrial Fibrillation
Cardiology · 26.06.2026 · 1-11
DOI: 10.1159/000553289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, online erschienen am 26.06.2026. Verfasst von Jumpei Yamamoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan, 09106y@gmail.com. Die Arbeit nennt 20 Literaturangaben.
Themen: Herzinsuffizienz, Schlaganfall
Abstract (Originalsprache)
Introduction
Whether the mortality impact of ischemic stroke and major bleeding differs across left ventricular ejection fraction (LVEF) categories in patients hospitalized for acute heart failure (AHF) with atrial fibrillation (AF) remains uncertain.
Methods
We retrospectively analyzed 716 patients hospitalized for AHF with prevalent AF (mean age: 79 ± 11 years; 49% female). During up to 3 years of follow-up (median: 1.4 years), 53 patients developed stroke and 89 developed major bleeding. Time-dependent Cox models were used to evaluate associations between poststroke and post-major bleeding states and all-cause and cardiovascular mortality, stratified by LVEF category: heart failure with reduced ejection fraction, mildly reduced ejection fraction, and preserved ejection fraction.
Results
There were 160 deaths, including 106 cardiovascular deaths. As first qualifying events, 34 were stroke-first, and 74 were bleeding-first, with the remaining patients experiencing death-first or being censored. In time-dependent Cox models, post-major bleeding status was associated with higher all-cause mortality, whereas the poststroke association was imprecise (hazard ratio [HR] 2.00, 95% confidence interval [CI] 1.22–3.28 vs. HR 1.35 [95% CI 0.67–2.70]). For cardiovascular death, neither exposure reached conventional statistical significance (HR 1.97 [95% CI 0.93–4.17] after stroke and 1.69 [0.88–3.26] after bleeding). LVEF-stratified estimates were imprecise, and interaction tests did not support definitive effect modification.
Conclusion
In patients hospitalized for AHF with prevalent AF, transition into a post-major bleeding state was associated with higher subsequent all-cause mortality, whereas the poststroke association was imprecise. LVEF-stratified findings were exploratory because interaction tests were not significant and event counts were limited. Bleeding-risk mitigation should accompany continued stroke prevention, not replace it.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan, 09106y@gmail.com.
- Department of Cardiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan, 09106y@gmail.com.
- Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan.
- Department of Cardiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
Zitieren
APA
Yamamoto, J., Nakamura, K., Hayama, H., Enomoto, Y., Yamamoto, M., Hara, H., Hara, H., & Hiroi, Y. (2026). Mortality Impact of Stroke and Major Bleeding across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure with Prevalent Atrial Fibrillation. Cardiology, 1-11. https://doi.org/10.1159/000553289
Vancouver
Yamamoto J, Nakamura K, Hayama H, Enomoto Y, Yamamoto M, Hara H, et al. Mortality Impact of Stroke and Major Bleeding across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure with Prevalent Atrial Fibrillation. Cardiology. 2026:1-11. doi:10.1159/000553289
BibTeX
@article{Yamamoto2026,
author = {Yamamoto, Jumpei and Nakamura, Keijiro and Hayama, Hiromasa and Enomoto, Yoshinari and Yamamoto, Masaya and Hara, Hidehiko and Hara, Hisao and Hiroi, Yukio},
title = {Mortality Impact of Stroke and Major Bleeding across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure with Prevalent Atrial Fibrillation},
journal = {Cardiology},
year = {2026},
pages = {1--11},
doi = {10.1159/000553289}
}
EUVIMED